- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02282969
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development
Objectives:
This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study.
The specific aims of the measures and decision aid development phase of this project are as follows:
Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers.
Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cognitive and Pilot Testing:
If you agree to take part in this study, you will take part in an interview with a member of the research staff. The interviewer will take notes of your responses. First, you will be asked some questions about you, like your age, sex, race, and education level. Then you will be asked to look at some educational materials about lung cancer screening. These could be written information, animations, graphics, videos, or questionnaires. You may be asked questions about:
- Lung cancer and lung cancer screening
- The length of the materials
- The balance of the information found in the materials
The study interview will take place in person at MD Anderson and will take between 1 and 1 ½ hours.
Your participation on this study will be over once the interview is complete.
This is an investigational study.
Up to 50 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events.
Measures Reliability Study:
If you agree to take part in this study, you will complete a questionnaire 2 times. The questionnaire will ask about:
- Lung cancer
- Lung cancer screening
- Making decisions about screening
- Your age, race, gender, and level of education
You will complete the first questionnaire in person. It will take about 20 minutes to fill out. Then, about 1 month later, you will be asked to fill out the questionnaire again.
The second time you can come in person, or fill out the questionnaire by mail or telephone. Your participation will be over when the second questionnaire is complete.
This is an investigational study.
Up to 150 participants will be enrolled in this part of the study. All will take part at MD Anderson, UTMB, the Galveston community, or tobacco-related community events.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Robert Volk, PHD
- Phone Number: 713-563-2509
- Email: BVolk@mdanderson.org
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77555
- Recruiting
- The University of Texas Medical Branch at Galveston
-
Houston, Texas, United States, 77030
- Recruiting
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men and women 55 to 80 years of age.
- Participants must speak English.
- Current smoker or quit smoking within the past 15 years.
Exclusion Criteria:
1. History of lung cancer.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Lung Cancer Screening Decision Aids
Participants are asked to look over education materials about lung cancer screening, and interviewed.
Some participants will look at a video patient decision aid, with an interview and questionnaire completion.
Some participants complete lung cancer screening knowledge questionnaire at first visit, and then again in one month.
|
Interviews performed by study staff encompassing lung cancer screening and patient decision aids.
Questionnaires completed after viewing patient decision aid video.
Questionnaires also completed regarding lung cancer screening knowledge at first visit, then again in one month.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Informed Decisions About Lung Cancer Screening (Data from interviews and questionnaires reviewed to assess participant knowledge)
Time Frame: 1 Month
|
Data from interviews and questionnaires reviewed to assess participant knowledge regarding lung cancer screening and decision aid.
|
1 Month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Paul Cinciripini, PHD, MS, BS, M.D. Anderson Cancer Center
- Study Chair: Robert Volk, PHD, M.D. Anderson Cancer Center
- Principal Investigator: Suzanne Linder, PHD, The University of Texas Medical Branch at Galveston
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PA14-0072
- CER-1306-03385 (Other Grant/Funding Number: Patient Centered Outcomes Research Institute)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Knowledge, Attitudes, Practice
-
Nigde Omer Halisdemir UniversityGazi University; Ankara Yildirim Beyazıt UniversityRecruitingHealth Knowledge, Attitudes, PracticeTurkey
-
Bournemouth UniversityUniversity College, London; University of Leeds; University of SouthamptonCompletedHealth Knowledge, Attitudes, PracticeUnited Kingdom
-
Galderma R&DCompletedHealth Knowledge, Attitudes, PracticeFrance, Germany, Spain, United Kingdom
-
Virginia Commonwealth UniversityCompletedHealth Knowledge, Attitudes, PracticeUnited States
-
Chang Gung Memorial HospitalCompletedHealth Knowledge, Attitudes, PracticeTaiwan
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Continuity Research NetworkCompletedHealth Knowledge, Attitudes, PracticeUnited States
-
Harvard School of Public Health (HSPH)RecruitingHealth Knowledge, Attitudes, PracticeUnited States
-
Harvard School of Public Health (HSPH)RecruitingHealth Knowledge, Attitudes, PracticeUnited States
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingHealth Knowledge, Attitudes, PracticeTurkey
Clinical Trials on Interviews
-
Institut Paoli-CalmettesNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Central Hospital, Nancy, FranceBeaujon Hospital; Société Francophone Nutrition Clinique et MétabolismeUnknownSBS - Short Bowel SyndromeFrance
-
University of Colorado, DenverOrthotic and Prosthetic Education and Research Foundation (OPERF)Active, not recruiting
-
Maastricht Radiation OncologyMaastricht University Medical Center; The Netherlands Cancer InstituteCompletedLarynx CancerNetherlands
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)Recruiting
-
Sandra BucciUniversity of Edinburgh; NHS Lothian; Manchester University NHS Foundation Trust and other collaboratorsCompletedChild Sexual Abuse, Confirmed, SequelaUnited Kingdom
-
Centre Hospitalier Régional Metz-ThionvilleNot yet recruiting
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); University of CalgaryCompletedPatient Engagement | Family Members | Gastro Intestinal BleedingCanada
-
University Hospital, LimogesUnknownAge-related Macular Degeneration (AMD)France